B. Celli and W. Macnee, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, European Respiratory Journal, vol.23, issue.6, pp.932-946, 2004.
DOI : 10.1183/09031936.04.00014304

S. Hurd and R. Pauwels, Global Initiative for Chronic Obstructive Lung Diseases (GOLD), Pulmonary Pharmacology & Therapeutics, vol.15, issue.4, pp.353-355, 2002.
DOI : 10.1006/pupt.2002.0381

. Atsou, Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, vol.22, issue.Suppl 43, p.7, 2011.
DOI : 10.1136/thorax.58.5.388

URL : https://hal.archives-ouvertes.fr/inserm-00565204

C. Mathers and D. Loncar, Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Medicine, vol.52, issue.11, p.442, 2006.
DOI : 10.1371/journal.pmed.0030442.st007

A. Jemal, E. Ward, Y. Hao, and M. Thun, Trends in the leading causes of death in the United States, pp.1255-1259, 1970.

C. Murray and A. Lopez, Alternative projections of mortality and disability by cause 1990???2020: Global Burden of Disease Study, The Lancet, vol.349, issue.9064, pp.1498-1504, 1997.
DOI : 10.1016/S0140-6736(96)07492-2

D. Bellamy, J. Bouchard, S. Henrichsen, G. Johansson, A. Langhammer et al., International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Chronic Obstructive Pulmonary Disease (COPD), Primary Care Respiratory Journal, vol.15, issue.1, pp.48-57, 2006.
DOI : 10.1016/j.pcrj.2005.11.003

. Société-de-pneumologie-de-langue-française, Recommendations of the Francophone Society of Pneumology for pulmonary rehabilitation in COPD] [Article in French], Rev Mal Respir, vol.22, pp.696-704, 2005.

A. Buist, M. Mcburnie, W. Vollmer, S. Gillespie, P. Burney et al., International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study, The Lancet, vol.370, issue.9589, pp.741-750, 2007.
DOI : 10.1016/S0140-6736(07)61377-4

A. Menezes, R. Perez-padilla, J. Jardim, A. Muiño, M. Lopez et al., Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study, The Lancet, vol.366, issue.9500, pp.1875-1881, 2005.
DOI : 10.1016/S0140-6736(05)67632-5

. Eurostat, Causes of death: Standardised death rate (per 100,000 inhabitants) (Annual Data)

A. Jaén, A. Ferrer, I. Ormaza, M. Rué, C. Domingo et al., Prevalencia de bronquitis cr??nica, asma y obstrucci??n al flujo a??reo en una zona urbano-industrial de Catalu??a, Archivos de Bronconeumolog??a, vol.35, issue.3, pp.122-128, 1999.
DOI : 10.1016/S0300-2896(15)30290-8

M. Jordán, L. , M. Berra, J. , C. Iñigo et al., Enfermedad pulmonar obstructiva cr??nica en la poblaci??n general. Estudio epidemiol??gico realizado en Guip??zcoa, Archivos de Bronconeumolog??a, vol.34, issue.1, pp.23-27, 1998.
DOI : 10.1016/S0300-2896(15)30501-9

B. Brotons, J. Pérez, F. Sánchez-toril, S. Soriano, J. Hernández et al., Prevalencia de la enfermedad pulmonar obstructiva cr??nica y del asma. Estudio transversal, Archivos de Bronconeumolog??a, vol.30, issue.3, pp.149-152, 1994.
DOI : 10.1016/S0300-2896(15)31109-1

D. Piperno, F. Bart, P. Serrier, M. Zureik, and L. Finkielsztejn, Patients ?? risque de broncho-pneumopathie chronique obstructive en m??decine g??n??rale, La Presse M??dicale, vol.34, issue.21, pp.1617-1622, 2005.
DOI : 10.1016/S0755-4982(05)84236-8

I. Cerveri, S. Accordini, A. Corsico, M. Zoia, L. Carrozzi et al., Chronic cough and phlegm in young adults, European Respiratory Journal, vol.22, issue.3, pp.413-417, 2003.
DOI : 10.1183/09031936.03.00121103

G. Huchon, A. Vergnenegre, F. Neukirch, G. Brami, N. Roche et al., Chronic bronchitis among French adults: high prevalence and underdiagnosis, European Respiratory Journal, vol.20, issue.4, pp.806-812, 2002.
DOI : 10.1183/09031936.02.00042002

I. Cerveri, S. Accordini, G. Verlato, A. Corsico, M. Zoia et al., Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults, European Respiratory Journal, vol.18, issue.1, pp.85-92, 2001.
DOI : 10.1183/09031936.01.00087101

M. Cazzola, G. Bettoncelli, E. Sessa, and C. Cricelli, Primary care of the patient with chronic obstructive pulmonary disease in Italy, Respiratory Medicine, vol.103, issue.4, pp.582-588, 2009.
DOI : 10.1016/j.rmed.2008.10.017

L. Schirnhofer, B. Lamprecht, W. Vollmer, M. Allison, M. Studnicka et al., Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest, COPD prevalence in Salzburg, vol.131, pp.29-36, 2007.

R. Montnemery, U. Nihlen, M. Andersson, L. Greiff, A. Johannisson et al., Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in, Int J Tuberc Lung Dis, vol.10, pp.490-498, 1992.

J. Hedman, J. Kaprio, T. Poussa, and M. Nieminen, Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study, International Journal of Epidemiology, vol.28, issue.4, pp.717-722, 1999.
DOI : 10.1093/ije/28.4.717

P. Montnemery, E. Adelroth, K. Heuman, A. Johannisson, S. Johansson et al., Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden, Respiratory Medicine, vol.92, issue.12, pp.1337-1345, 1998.
DOI : 10.1016/S0954-6111(98)90139-1

B. Lundback, L. Nystrom, L. Rosenhall, and N. Stjernberg, Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey, Eur Respir J, vol.4, pp.257-266, 1991.

M. Miravitlles, J. Soriano, F. Garcia-rio, L. Munoz, E. Duran-tauleria et al., Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities, Thorax, vol.64, issue.10, pp.863-868, 2009.
DOI : 10.1136/thx.2009.115725

Y. Van-durme, K. Verhamme, T. Stijnen, F. Van-rooij, G. Van-pottelberge et al., Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly, Chest, vol.135, issue.2, pp.368-377, 2009.
DOI : 10.1378/chest.08-0684

J. Hansen, L. Pedersen, K. Overvad, Ø. Omland, H. Jensen et al., The Prevalence of Chronic Obstructive Pulmonary Disease among Danes Aged 45???84 Years: Population-based Study, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.169, issue.6, pp.347-352, 2008.
DOI : 10.1136/bmj.324.7350.1370

M. Bednarek, J. Maciejewski, M. Wozniak, P. Kuca, and J. Zielinski, Prevalence, severity and underdiagnosis of COPD in the primary care setting, Thorax, vol.63, issue.5, pp.402-407, 2008.
DOI : 10.1136/thx.2007.085456

N. Roche, F. Dalmay, T. Perez, C. Kuntz, A. Vergnenegre et al., Impact of chronic airflow obstruction in a working population, European Respiratory Journal, vol.31, issue.6, pp.1227-1233, 2008.
DOI : 10.1183/09031936.00089607

L. Shahab, M. Jarvis, J. Britton, and R. West, Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample, Thorax, vol.61, issue.12, pp.1043-1047, 2006.
DOI : 10.1136/thx.2006.064410

K. Stavem, L. Sandvik, and J. Erikssen, Can Global Initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? Chest, pp.318-325, 2006.

L. Sichletidis, I. Tsiotsios, A. Gavriilidis, D. Chloros, I. Kottakis et al., Prevalence of Chronic Obstructive Pulmonary Disease and Rhinitis in Northern Greece, Respiration, vol.72, issue.3, pp.270-277, 2005.
DOI : 10.1159/000085368

E. Murtagh, L. Heaney, J. Gingles, R. Shepherd, F. Kee et al., The prevalence of obstructive lung disease in a general population sample: The NICECOPD study, European Journal of Epidemiology, vol.9, issue.suppl 5, pp.443-453, 2005.
DOI : 10.1007/s10654-005-1248-8

N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas, Prevalence of COPD in Greece, Chest, vol.125, issue.3, pp.892-900, 2004.
DOI : 10.1378/chest.125.3.892

M. Hasselgren, A. M. Lindahl, A. Janson, S. Lundback, and B. , Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care, Scandinavian Journal of Primary Health Care, vol.19, issue.1
DOI : 10.1080/028134301300034701

V. Peña, M. Miravitlles, R. Gabriel, C. Jiménez-ruiz, C. Villasante et al., Geographic Variations in Prevalence and Underdiagnosis of COPD, Chest, vol.118, issue.4, pp.981-989, 2000.
DOI : 10.1378/chest.118.4.981

G. Viegi, M. Pedreschi, F. Pistelli, D. Pede, F. Baldacci et al., Prevalence of Airways Obstruction in a General Population, Chest, vol.117, issue.5, pp.339-345, 2000.
DOI : 10.1378/chest.117.5_suppl_2.339S

J. Dickinson, M. Meaker, M. Searle, and G. Ratcliffe, Screening older patients for obstructive airways disease in a semi-rural practice, Thorax, vol.54, issue.6, pp.501-505, 1999.
DOI : 10.1136/thx.54.6.501

D. Renwick and M. Connolly, Prevalence and treatment of chronic airways obstruction in adults over the age of 45., Thorax, vol.51, issue.2, pp.164-168, 1996.
DOI : 10.1136/thx.51.2.164

P. Bakke, V. Baste, R. Hanoa, and A. Gulsvik, Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents., Thorax, vol.46, issue.12, pp.863-870, 1991.
DOI : 10.1136/thx.46.12.863

J. Peabody, B. Schau, M. Lopez-vidriero, J. Vestbo, S. Wade et al., COPD: A prevalence estimation model, Respirology, vol.134, issue.5, pp.594-602, 2005.
DOI : 10.1378/chest.117.2_suppl.5S

T. Feenstra, M. Van-genugten, R. Hoogenveen, and E. Wouters, The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.4, pp.590-596, 2001.
DOI : 10.1164/ajrccm.164.4.2003167

P. Stang, E. Lydick, C. Silberman, A. Kempel, and E. Keating, The Prevalence of COPD, Chest, vol.117, issue.5, pp.354-359, 2000.
DOI : 10.1378/chest.117.5_suppl_2.354S

N. Siafakas, P. Vermeire, N. Pride, P. Paoletti, J. Gibson et al., Optimal assessment and management of chronic obstructive pulmonary disease (COPD), European Respiratory Journal, vol.8, issue.8, pp.1398-1420, 1995.
DOI : 10.1183/09031936.95.08081398

. Atsou, Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, vol.22, issue.Suppl 43, p.7, 2011.
DOI : 10.1136/thorax.58.5.388

URL : https://hal.archives-ouvertes.fr/inserm-00565204

K. Rabe, S. Hurd, A. Anzueto, P. Barnes, S. Buist et al., Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.6, pp.532-555, 2007.
DOI : 10.1164/rccm.200703-456SO

A. Lindberg, A. Bjerg-backlund, E. Ronmark, L. Larsson, and B. Lundback, Corrigendum to: ???Prevalence and underdiagnosis of COPD by disease severity and attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies???, Respiratory Medicine, vol.101, issue.12, pp.264-272, 2006.
DOI : 10.1016/j.rmed.2007.07.019

D. Marco, R. Accordini, S. Cerveri, I. Corsico, A. Sunyer et al., An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages, Thorax, vol.59, issue.2, pp.120-125, 2004.
DOI : 10.1136/thorax.2003.011163

S. Jansson, F. Andersson, S. Borg, Å. Ericsson, E. Jönsson et al., Costs of COPD in Sweden According to Disease Severity, Chest, vol.122, issue.6, pp.1994-2002, 2002.
DOI : 10.1378/chest.122.6.1994

V. Hertzen, L. Reunanen, A. Impivaara, O. Malkia, E. Aromaa et al., Airway obstruction in relation to symptoms in chronic respiratory disease???a nationally representative population study, Respiratory Medicine, vol.94, issue.4, pp.356-363, 2000.
DOI : 10.1053/rmed.1999.0715

J. Izquierdo, C. Barcina, J. Jimenez, M. Munoz, and M. Leal, Study of the burden on patients with chronic obstructive pulmonary disease, International Journal of Clinical Practice, vol.166, issue.Suppl. 2, pp.87-97, 2009.
DOI : 10.1111/j.1742-1241.2008.01936.x

M. Hoogendoorn, T. Feenstra, T. Schermer, and A. Hesselink, Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice, Respiratory Medicine, vol.100, issue.1, pp.83-86, 2006.
DOI : 10.1016/j.rmed.2005.04.004

B. Detournay, C. Pribil, M. Fournier, B. Housset, G. Huchon et al., The SCOPE Study: Health-Care Consumption Related to Patients with Chronic Obstructive Pulmonary Disease in France, Value in Health, vol.7, issue.2, pp.168-174, 2004.
DOI : 10.1111/j.1524-4733.2004.72329.x

J. Soriano, W. Maier, P. Egger, G. Visick, B. Thakrar et al., Recent trends in physician diagnosed COPD in women and men in the UK, Thorax, vol.55, issue.9, pp.789-794, 2000.
DOI : 10.1136/thorax.55.9.789

J. Soler-cataluña, M. Martínez-garcía, R. Sánchez, P. Salcedo, E. Navarro et al., Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease, Thorax, vol.60, issue.11, pp.925-931, 2005.
DOI : 10.1136/thx.2005.040527

M. Tsoumakidou, N. Tzanakis, O. Voulgaraki, I. Mitrouska, G. Chrysofakis et al., Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions?, Respiratory Medicine, vol.98, issue.2, pp.178-183, 2004.
DOI : 10.1016/j.rmed.2003.09.011

O. Kornmann, K. Beeh, J. Beier, U. Geis, M. Ksoll et al., Newly Diagnosed Chronic Obstructive Pulmonary Disease, Respiration, vol.70, issue.1, pp.67-75, 2003.
DOI : 10.1159/000068417

P. Burge, P. Calverley, P. Jones, S. Spencer, and J. Anderson, Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study, Thorax, vol.58, issue.8, pp.654-658, 2003.
DOI : 10.1136/thorax.58.8.654

P. Calverley, R. Pauwels, J. Vestbo, P. Jones, N. Pride et al., Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial, The Lancet, vol.361, issue.9356, pp.449-456, 2003.
DOI : 10.1016/S0140-6736(03)12459-2

P. Jones, L. Willits, P. Burge, and P. Calverley, Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations, European Respiratory Journal, vol.21, issue.1, pp.68-73, 2003.
DOI : 10.1183/09031936.03.00013303

F. Andersson, S. Borg, S. Jansson, A. Jonsson, A. Ericsson et al., The costs of exacerbations in chronic obstructive pulmonary disease (COPD), Respiratory Medicine, vol.96, issue.9, pp.700-708, 2002.
DOI : 10.1053/rmed.2002.1334

P. Burge, P. Calverley, P. Jones, S. Spencer, J. Anderson et al., Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, issue.7245, pp.1297-1303, 2000.
DOI : 10.1136/bmj.320.7245.1297

T. Effing, H. Kerstjens, P. Van-der-valk, G. Zielhuis, and J. Van-der-palen, (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study, Thorax, vol.64, issue.11, pp.956-962, 2009.
DOI : 10.1136/thx.2008.112243

H. Worth, C. Schacher, and U. Dethlefsen, Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial, Respiratory Research, vol.365, issue.8, p.69, 2009.
DOI : 10.1016/S0140-6736(05)66456-2

T. Schermer, N. Chavannes, R. Dekhuijzen, E. Wouters, J. Muris et al., Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis, Respiratory Medicine, vol.103, issue.4, pp.542-551, 2009.
DOI : 10.1016/j.rmed.2008.11.003

O. Reilly, J. Williams, A. Holt, K. Rice, and L. , Defining COPD exacerbations: impact on estimation of incidence and burden in primary care, Primary Care Respiratory Journal, vol.15, issue.6, pp.346-353, 2006.
DOI : 10.1016/j.pcrj.2006.08.009

T. Wilkinson, G. Donaldson, S. Johnston, P. Openshaw, and J. Wedzicha, Decline in Patients with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.8, pp.871-876, 2006.
DOI : 10.1164/rccm.200509-1489OC

G. Donaldson, T. Seemungal, I. Patel, S. Lloyd-owen, T. Wilkinson et al., Longitudinal changes in the nature, severity and frequency of COPD exacerbations, European Respiratory Journal, vol.22, issue.6, pp.931-936, 2003.
DOI : 10.1183/09031936.03.00038303

T. Seemungal, G. Donaldson, A. Bhowmik, D. Jeffries, and J. Wedzicha, Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.5, pp.1608-1613, 2000.
DOI : 10.1164/ajrccm.161.5.9908022

T. Seemungal, T. Wilkinson, J. Hurst, W. Perera, R. Sapsford et al., Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.11, pp.1139-1147, 2008.
DOI : 10.1164/rccm.200801-145OC

D. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten et al., A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.359, issue.15, pp.1543-1554, 2008.
DOI : 10.1056/NEJMoa0805800

P. Calverley, S. Rennard, H. Nelson, J. Karpel, E. Abbate et al., One-year treatment with mometasone furoate in chronic obstructive pulmonary disease, Respiratory Research, vol.58, issue.10, p.73, 2008.
DOI : 10.1136/thorax.58.10.855

J. Wedzicha, P. Calverley, T. Seemungal, G. Hagan, Z. Ansari et al., The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.1, pp.19-26, 2008.
DOI : 10.1164/rccm.200707-973OC

D. Dusser, M. Bravo, and P. Iacono, The effect of tiotropium on exacerbations and airflow in patients with COPD, European Respiratory Journal, vol.27, issue.3, pp.547-555, 2006.
DOI : 10.1183/09031936.06.00062705

J. Oostenbrink, M. Rutten-van-mölken, M. Al, J. Van-noord, and W. Vincken, ipratropium to treat chronic obstructive pulmonary disease, European Respiratory Journal, vol.23, issue.2, pp.241-249, 2004.
DOI : 10.1183/09031936.03.00083703

V. Brusasco, R. Hodder, M. Miravitlles, L. Korducki, L. Towse et al., Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD, Thorax, vol.58, issue.5, pp.399-404, 2003.
DOI : 10.1136/thorax.58.5.399

S. Borg, A. Ericsson, J. Wedzicha, A. Gulsvik, B. Lundback et al., A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease, Value in Health, vol.7, issue.2, pp.153-167, 2004.
DOI : 10.1111/j.1524-4733.2004.72318.x

S. Hurd, The Impact of COPD on Lung Health Worldwide, Chest, vol.117, issue.2, pp.1-4, 2000.
DOI : 10.1378/chest.117.2_suppl.1S

K. Groenewegen, A. Schols, and E. Wouters, Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD*, Chest, vol.124, issue.2, pp.459-467, 2003.
DOI : 10.1378/chest.124.2.459

P. Almagro, E. Calbo, A. Ochoa-de-echaguen, B. Barreiro, S. Quintana et al., Mortality After Hospitalization for COPD, Chest, vol.121, issue.5, pp.1441-1448, 2002.
DOI : 10.1378/chest.121.5.1441

G. Gudmundsson, T. Gislason, E. Lindberg, R. Hallin, C. Ulrik et al., Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity, Respiratory Research, vol.350, issue.Suppl 5, p.109, 2006.
DOI : 10.1056/NEJMoa021322

M. Arne, K. Lisspers, B. Stallberg, G. Boman, H. Hedenstrom et al., How often is diagnosis of COPD confirmed with spirometry?, Respiratory Medicine, vol.104, issue.4, pp.550-556, 2010.
DOI : 10.1016/j.rmed.2009.10.023

R. Jones, G. Donaldson, N. Chavannes, K. Kida, M. Dickson-spillmann et al., Derivation and Validation of a Composite Index of Severity in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.12, pp.1189-1195, 2009.
DOI : 10.1164/rccm.200902-0271OC

M. Puhan, J. Garcia-aymerich, M. Frey, G. Ter-riet, J. Antó et al., Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index, The Lancet, vol.374, issue.9691, pp.704-711, 2009.
DOI : 10.1016/S0140-6736(09)61301-5

S. Aaron, D. Fergusson, G. Marks, S. Suissa, K. Vandemheen et al., Counting, analysing and reporting exacerbations of COPD in randomised controlled trials, Thorax, vol.63, issue.2, pp.122-128, 2008.
DOI : 10.1136/thx.2007.082636

. Atsou, Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, vol.22, issue.Suppl 43, p.7, 2011.
DOI : 10.1136/thorax.58.5.388

URL : https://hal.archives-ouvertes.fr/inserm-00565204

R. Anderson, A. Minino, D. Hoyert, and H. Rosenberg, Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates, Natl Vital Stat Rep, vol.49, pp.1-32, 2001.

D. Mannino, A. Buist, T. Petty, P. Enright, and S. Redd, Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study, Thorax, vol.58, issue.5, pp.388-393, 2003.
DOI : 10.1136/thorax.58.5.388

R. Loddenkemper, G. Gibson, and Y. Sibille, The burden of lung disease in Europe, 2003.

P. Burney, S. Suissa, J. Soriano, W. Vollmer, G. Viegi et al., The pharmacoepidemiology of COPD: recent advances and methodological discussion, Eur Respir J, pp.2241-2285, 2003.

. Atsou, Cite this article as Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, p.7, 2011.

A. Figure, . Copd, A. Estimates, . Austria, . Dk et al., Chronic Obstructive Pulmonary Disease; NS, Not specified.! * Symptoms correspond to cough and sputum at least 3 months each year. These patients had chronic bronchitis.! ? Functional respiratory tests: FEV1/FVC<70% and FEV1<80% of predicted or FEV1/FVC<65% or FEV1/FVC<70% or FEV1/FVC< 88% (male)/ 89% (female)! ? Abbreviations for countries: United Kingdom; EU, 16 European Union Countries.! § Abbreviations for types of population: GP, general population; HP, health prevention center; TP, total population; OC, occupational cohort; PC, primary care.! # Age was reported in various ways distinguished here as follows: !? x", minimum age; "x" or "x(y)", mean age or mean age (SD); "{x-y}", age range i.e. {min-max}.! ? These data are also reported in Schirnhofer! ** Prevalence estimates based on the European Respiratory Society?s statement or based on " clinical " criteria (FEV1/FVC < 70%) correspond to 11% and 18, 3%, respectively.! 0%! 20%! 40%! 60%! 80%! 100%! AT, pp.14-51, 2000.

A. Figure, . Copd, D. Data, . Denmark, . Fi et al., Text abbreviations: COPD, Chronic Obstructive Pulmonary Disease; GPCS, General Practitioner and/or Chest Specialist.! *Abbreviations for countries: AT, Austria, 16 European Union Countries.! ?Abbreviations for classifications: ERS, 1995.

B. , B. T. Society, S. !. Société-de-pneumonologie-de-langue-française-classifications, E. ?the, . Ats et al., classifications only define three stages.! §In this study, based on GOLD 2003 severity scale, the estimates in stage 0 defining persons at risk of COPD ranged from 51.7% in Switzerland to 89.8% in Spain.! #Persons with both FEV1/FVC<70% and FEV1?80% (considered as having COPD in the GOLD 2006 classification but not in the BTS 1995 classification) were also included in the study.! ?Airway obstruction of any degree was defined by FEV1/FVC<70% and the severity of obstruction was graded according to the FEV1 value: mild (FEV1?70% of predicted) and moderate-severe, 1995.

*. Airway, 80% and the severity of obstruction was graded according to the FEV1/FVC value: 70-79%, minimal to mild; 50-69%, moderate; <50%, severe.! Males! Females! -40! -20! 0! 20! 40! 60!, 1988.

M. L. Mortality and !. A. , year(s)!

A. , A. Be, . Belgium, . Bu, . Bulgaria et al., associated codes were used: [10], version 10 and codes J40?J44 and J47 (excepted for Greece where the estimates correspond to codes J40?J47); [45], version 9 and codes 490?493; [78], version 9 and codes 490-496. ! COPD, Chronic Obstructive Pulmonary Disease.! Abbreviations for countries, the three mentioned references, the following versions of the International Classification of the Disease and